BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 23c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.05, $0.23 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $10.47 million versus the consensus estimate of $88.3 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Iran Has Resumed Producing Ballistic Missiles, U.S. and Middle East Officials Say - WSJ
• GLJ Research rips into SolarEdge Technologies (SEDG): 'We'd be aggressively fading this move'
• Market Vectors Oil Services ETF (OIH) call put ratio 3.4 calls to 1 put with a focus on October calls as share price down 1.9%